Your browser doesn't support javascript.
loading
B cell depletion with rituximab in the treatment of primary Sjögren's syndrome: what have we learnt?
Grigoriadou, Sofia; Chowdhury, Farzana; Pontarini, Elena; Tappuni, Anwar; Bowman, Simon J; Bombardieri, Michele.
  • Grigoriadou S; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, UK.
  • Chowdhury F; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, and Department of Oral Medicine, Institute of Dentistry, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, UK.
  • Pontarini E; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, UK.
  • Tappuni A; Department of Oral Medicine, Institute of Dentistry, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, UK.
  • Bowman SJ; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, and Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Bombardieri M; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, UK. m.bombardieri@qmul.ac.uk.
Clin Exp Rheumatol ; 37 Suppl 118(3): 217-224, 2019.
Article en En | MEDLINE | ID: mdl-31464681
Asunto(s)
Search on Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Linfocitos B / Síndrome de Sjögren / Rituximab Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article
Search on Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Linfocitos B / Síndrome de Sjögren / Rituximab Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article